552-37-4Relevant articles and documents
Di- and triorganotin(IV) complexes of 2-aminobenzoic acid with and without triphenylphosphine: Synthesis, spectroscopy, semi-empirical study, and antimicrobial activities
Amin, Muhammad Mohsin,Ali, Saqib,Shahzadi, Saira,Sharma, Saroj K.,Qanungo, Kushal
, p. 337 - 350 (2011)
Eight organotin carboxylates have been synthesized in quantitative yield by reaction of NaL (L = 2-aminobenzoate) with the di- and triorganotin chlorides and triphenylphosphine. All the complexes have been characterized by elemental analysis, IR, multinuclear NMR (1H, 13C, and 119Sn), and mass spectrometry. The spectroscopic data indicate 1 : 2/1 : 1 M : L stoichiometry in 1, 3, 5, and 7 and 1 : 2 : 1/1 : 1 : 1 M : L : PPh3 stoichiometry in 2, 4, 6, and 8. FT-IR spectra clearly demonstrate metal attachment with both oxygens of the ligand and bidentate coordination in 1, 3, 5, and 7 while monodentate ligand for 2, 4, 6, and 8. In solid state, 1, 2, 5, and 6 exhibit six coordination whereas 3, 4, 7, and 8 show five coordination. The structural behavior is confirmed by semi-empirical study. NMR data reveal four-coordinate geometry in solution. These complexes were screened for antimicrobial activity invitro. The screening tests show that tributyltin carboxylates are more potent antibacterial and fungicidal agents than corresponding methyl derivatives, and triphenylphosphine enhances the antibacterial and fungicidal activities of these complexes.
Anti-inflammatory and anti-ulcer compounds and process
-
, (2008/06/13)
Disclosed herein are anti-inflammatory and anti-ulcer copper coordination compounds and a process for using them in the treatment of arthritis and gastrointestinal ulcers in animal bodies. The copper coordination compounds utilized are the reaction products of copper salts with: 1. aromatic carboxylic acids or their alkaline earth salts; 2. heterocyclic carboxylic acids or their alkaline earth salts; 3. amino acids or their alkaline earth salts; 4. amines; and 5. suitably substituted steroids. The process disclosed comprises administering to experimental animals, orally or parentrally (subcutaneously), in controlled dosages, the aforementioned copper coordination compounds for the treatment of inflammation (i.e., arthritis) and ulcers of the gastrointestinal tract.